SS

Samuel Scofield

Senior Associate at Good Growth Capital

New York, New York

Overview 

Samuel Scofield is currently a Senior Associate at Good Growth Capital, where he focuses on investing in life sciences companies at various stages, including Series A and Seed, across sectors such as Consumer Health, BioTech, and Digital Health. With a background in strategy consulting and previous roles at L.E.K. Consulting and Prescient Healthcare Group, Samuel brings expertise in evaluating and supporting innovative healthcare startups, while also serving as a Board Observer for companies like Spiro Robotics and VenoStent, Inc.

Work Experience 

  • Senior Associate

    2023 - Current

  • Associate

    2022 - 2023

    Investing in early-stage life sciences companies Therapeutics: AdipoPharma, Tevard Biosciences Medical devices: Avisi Technologies, Coaptech, Pleural Dynamics, Relief Cardiovascular, Spiro Robotics, Venostent Diagnostics: AOA Dx Biomanufacturing: Aralez Bio Ag-Biotech: Robigo

Good Growth Capital invests in early-stage transformative science- and technology-based companies

  • Board Observer

    2025

Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.

Raised $10,225,500.00 from Life Sciences Greenhouse of Pennsylvania, Life Science Angels, Kyto Technology and Life Science Inc, Ben Franklin Technology Partners of Southeastern Pennsylvania, Gaingels, Good Growth Capital, Mountain State Capital, Sunstone Management, Accanto Partners and MedVenture Partners.

  • Board Observer

    2024

  • Board Observer

    2023

  • Board Observer

    2023

AOA Dx is a biotech company developing cancer diagnostics in the field of women’s health.

Raised $24,500,000.00 from Gore Range Capital, LabCorp Venture Fund, Good Growth Capital, Astia, The Helm, RH Capital, LongeVC, VU Venture Partners, Cancer Fund and Adaptive Capital Partners.

  • Board Observer

    2023

  • Board Observer

    2023

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Raised $29,818,706.00 from Good Growth Capital, Norwest Venture Partners, IAG Capital Partners, Creative Ventures, SNR.vc, TMC Venture Fund, IAG Capital Partners, Alumni Ventures and Baylor Angel Network.

  • Associate

    2022 - 2022

  • Senior Analyst

    2020 - 2022

Articles About Samuel

Relevant Websites